☰

Robert D. Arnold, Ph.D. - Publications

Affiliations: 
1997-2005 Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
 2003-2005 Non-Invasive Small Animal Imaging Roswell Park Cancer Institute, Buffalo, NY, United States 
 2005-2012 Pharmaceutical and Biomedical Sciences University of Georgia, Athens, Athens, GA, United States 
 2012- Drug Discovery & Development Auburn University, Auburn, AL, United States 
Area:
Drug Delivery, Nanomedicine, Liposomes, Pharmaceutics, PK/PD, Cancer Therapeutics
Website:
http://www.auburn.edu/academic/pharmacy/directory/robert-arnold.html
Tree Info Similar researchers PubMed Report error

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Jukier T, Zhang C, Arnold RD, Gross A. Single intravenous and oral dose pharmacokinetics of the antiseizure medication brivaracetam in healthy cats. Journal of Veterinary Pharmacology and Therapeutics. PMID 39018069 DOI: 10.1111/jvp.13473  0.485
2023 Alhowail AH, Eggert M, Bloemer J, Pinky PD, Woodie L, Bhattacharya S, Bhattacharya D, Buabeid MA, Smith B, Dhanasekaran M, Piazza G, Reed MN, Escobar M, Arnold RD, Suppiramaniam V. Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment. Plos One. 18: e0294280. PMID 37948406 DOI: 10.1371/journal.pone.0294280  0.773
2023 Kennerly R, Coleman AE, Jasper SL, Arnold RD, Brainard BM. Effects of orally administered pimobendan on platelet function in healthy adult cats. American Journal of Veterinary Research. 1-7. PMID 37491004 DOI: 10.2460/ajvr.23.05.0103  0.535
2023 Mitra Ghosh T, Mazumder S, Davis J, Yadav J, Akinpelu A, Alnaim A, Kumar H, Waliagha R, Church Bird AE, Rais-Bahrami S, Bird RC, Mistriotis P, Mishra A, Yates CC, Mitra AK, ... Arnold RD, et al. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. Cancer Research Communications. 3: 1286-1311. PMID 37476073 DOI: 10.1158/2767-9764.CRC-22-0427  0.793
2023 Poudel I, Annaji M, Zhang C, Panizzi PR, Arnold RD, Kaddoumi A, Amin RH, Lee S, Shamsaei N, Babu RJ. Gentamicin Eluting 3D-Printed Implants for Preventing Post-Surgical Infections in Bone Fractures. Molecular Pharmaceutics. PMID 37455392 DOI: 10.1021/acs.molpharmaceut.3c00373  0.667
2023 Habbit NL, Anbiah B, Suresh J, Anderson L, Davies ML, Hassani I, Ghosh TM, Greene MW, Prabhakarpandian B, Arnold RD, Lipke EA. Ratiometric Inclusion of Fibroblasts Promotes Both Castration-Resistant And Androgen-Dependent Tumorigenic Progression in Engineered Prostate Cancer Tissues. Advanced Healthcare Materials. e2301139. PMID 37450342 DOI: 10.1002/adhm.202301139  0.804
2023 Davis JT, Ghosh TM, Mazumder S, Mitra A, Bird RC, Arnold RD. Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences. 24. PMID 37239838 DOI: 10.3390/ijms24108490  0.792
2022 Mazumder S, Mitra Ghosh T, Mukherjee UK, Chakravarti S, Amiri F, Waliagha RS, Hemmati F, Mistriotis P, Ahmed S, Elhussin I, Salam AB, Dean-Colomb W, Yates C, Arnold RD, Mitra AK. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers. 14. PMID 36497496 DOI: 10.3390/cancers14236009  0.749
2022 Alrbyawi H, Boddu SHS, Poudel I, Annaji M, Mita N, Arnold RD, Tiwari AK, Babu RJ. Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines. International Journal of Molecular Sciences. 23. PMID 36233061 DOI: 10.3390/ijms231911763  0.751
2022 Feugang JM, Ishak GM, Eggert MW, Arnold RD, Rivers OS, Willard ST, Ryan PL, Gastal EL. Intrafollicular injection of nanomolecules for advancing knowledge on folliculogenesis in livestock. Theriogenology. 192: 132-140. PMID 36099803 DOI: 10.1016/j.theriogenology.2022.08.032  0.785
2022 Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, Babu RJ. pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines. Pharmaceutics. 14. PMID 35745701 DOI: 10.3390/pharmaceutics14061128  0.738
2022 Habbit NL, Anbiah B, Anderson L, Suresh J, Hassani I, Eggert M, Brannen A, Davis J, Tian Y, Prabhakarpandian B, Panizzi P, Arnold RD, Lipke EA. Tunable three-dimensional engineered prostate cancer tissues for in vitro recapitulation of heterogeneous in vivo prostate tumor stiffness. Acta Biomaterialia. PMID 35551999 DOI: 10.1016/j.actbio.2022.05.011  0.808
2022 Alrbyawi H, Poudel I, Annaji M, Arnold RD, Tiwari AK, Babu RJ. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery. Pharmaceutical Nanotechnology. PMID 35156590 DOI: 10.2174/2211738510666220214102626  0.766
2021 Mitra Ghosh T, Kansom T, Mazumder S, Davis J, Alnaim AS, Jasper SL, Zhang C, Bird A, Opanasopit P, Mitra AK, Arnold RD. . The Journal of Pharmacology and Experimental Therapeutics. PMID 34949650 DOI: 10.1124/jpet.121.000898  0.777
2021 Mitra Ghosh T, White J, Davis J, Mazumder S, Kansom T, Skarupa E, Barnett GS, Piazza GA, Bird RC, Mitra AK, Yates C, Cummings BS, Arnold RD. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Frontiers in Pharmacology. 12: 736951. PMID 34938177 DOI: 10.3389/fphar.2021.736951  0.818
2021 Kurakula M, Chen L, Tiwari AK, Srinivas NR, Dash RP, Panizzi PR, Arnold RD, Babu RJ. Recent Advances in Lipid-Based Nanovesicular Delivery Systems for Melanoma Therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 38: 1-38. PMID 34369738 DOI: 10.1615/CritRevTherDrugCarrierSyst.2021034903  0.656
2021 Alhowail AH, Pinky PD, Eggert M, Bloemer J, Woodie LN, Buabeid MA, Bhattacharya S, Jasper SL, Bhattacharya D, Dhanasekaran M, Escobar M, Arnold RD, Suppiramaniam V. Doxorubicin induces dysregulation of AMPA receptor and impairs hippocampal synaptic plasticity leading to learning and memory deficits. Heliyon. 7: e07456. PMID 34296005 DOI: 10.1016/j.heliyon.2021.e07456  0.765
2020 Fu X, Eggert M, Yoo S, Patel N, Zhong J, Steinke I, Govindarajulu M, Turumtay EA, Mouli S, Panizzi P, Beyers R, Denney T, Arnold R, Amin RH. The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin. Frontiers in Pharmacology. 11: 574656. PMID 33912028 DOI: 10.3389/fphar.2020.574656  0.615
2020 Najahi-Missaoui W, Arnold RD, Cummings BS. Safe Nanoparticles: Are We There Yet? International Journal of Molecular Sciences. 22. PMID 33396561 DOI: 10.3390/ijms22010385  0.594
2020 Al Saqr A, Aldawsari MF, Alrbyawi H, Poudel I, Annaji M, Mulabagal V, Ramani MV, Gottumukkala S, Tiwari AK, Dhanasekaran M, Panizzi PR, Arnold RD, Babu RJ. Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells. Aaps Pharmscitech. 21: 304. PMID 33150503 DOI: 10.1208/s12249-020-01846-2  0.795
2020 Al Saqr A, Majrashi M, Alrbyawi H, Govindarajulu M, Fujihashi A, Gottumukkala S, Poudel I, Arnold RD, Babu RJ, Dhanasekaran M. Elucidating the anti-melanoma effect and mechanisms of Hispolon. Life Sciences. 117702. PMID 32387411 DOI: 10.1016/J.Lfs.2020.117702  0.766
2020 Alnaim AS, Arnold R, Eggert M, Nie B, Jasper S, Davis J, Panizzi P, Cummings B, Quach N. Role of PLA2R1 and sPLA2 on Drug Release and Uptake of Liposome Nanoparticles in Prostate Cancer The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03071  0.789
2019 Alrbyawi H, Poudel I, Dash RP, Srinivas NR, Tiwari AK, Arnold RD, Babu RJ. Role of Ceramides in Drug Delivery. Aaps Pharmscitech. 20: 287. PMID 31410612 DOI: 10.1208/S12249-019-1497-6  0.761
2019 Quach ND, Kaur SP, Eggert MW, Ingram L, Ghosh D, Sheth S, Nagy T, Dawson MR, Arnold RD, Cummings BS. Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. Scientific Reports. 9: 11478. PMID 31391540 DOI: 10.1038/S41598-019-47874-2  0.801
2019 Alhowail AH, Bloemer J, Pinky PD, Bhattacharya S, Majrashi M, Yongli Z, Bhattacharya D, Eggert M, Woodie L, Buabeid MA, Johnson N, Broadwater A, Smith B, Dhanasekaran M, Arnold RD, et al. Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicology Mechanisms and Methods. 1-33. PMID 31010378 DOI: 10.1080/15376516.2019.1600086  0.779
2019 Chen L, Alrbyawi H, Poudel I, Arnold RD, Babu RJ. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. Aaps Pharmscitech. 20: 99. PMID 30719596 DOI: 10.1208/S12249-019-1316-0  0.767
2019 Alnaim AS, Eggert MW, Nie B, Quanch ND, Jasper SL, Davis J, Barnett GS, Cummings BS, Panizzi PR, Arnold RD. Abstract 2985: Identifying uptake and biodistribution of liposome nanoparticles associated with secretes phospholipase A2proteins and PLA2receptors within a prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2985  0.789
2019 Ghosh TM, Davis J, Barnett GS, Skarupa E, Warner JD, Cummings BS, Arnold RD. Abstract 2944: Identification of key transcriptomic and epigenomic factors influencing conventional and metronomic dosing in aggressive and non-aggressive prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2944  0.79
2019 Kaur SP, Lee HK, Arnold RD, Cummings BS. Abstract 1913: Role of glypican 1 in regulating fibroblast activation in the prostate cancer tumor microenvironment Cancer Research. 79: 1913-1913. DOI: 10.1158/1538-7445.Sabcs18-1913  0.685
2019 Anbiah B, Hassani I, Habbit N, Jasper L, Ramsay D, Prabhakarpandian B, Arnold R, Lipke E. Abstract 999: In vivo breast tumor stiffness and vascular drug delivery recapitulated in a microfluidic tumor-on-a-chip Cancer Research. 79: 999-999. DOI: 10.1158/1538-7445.Am2019-999  0.745
2019 Jasper SL, Skarupa EB, Cummings BS, Arnold RD. Abstract 991: Secretory phospholipase A2 as a trigger for drug release in the treatment of triple-negative breast cancer Cancer Research. 79: 991-991. DOI: 10.1158/1538-7445.Am2019-991  0.683
2019 Habbit NL, Anbiah B, Anderson LS, Suresh J, Hassani I, Eggert M, Jasper SL, Prabhakarpandian B, Arnold RD, Lipke EA. Abstract 1915:In vivoprostate tumor tissue stiffness differs by tumor region and can be recapitulated in bioengineered prostate tumor tissues Cancer Research. 79: 1915-1915. DOI: 10.1158/1538-7445.Am2019-1915  0.81
2018 Osekavage KE, Brainard BM, Lane SL, Almoslem M, Arnold RD, Koenig A. Pharmacokinetics of tranexamic acid in healthy dogs and assessment of its antifibrinolytic properties in canine blood. American Journal of Veterinary Research. 79: 1057-1063. PMID 30256146 DOI: 10.2460/Ajvr.79.10.1057  0.777
2018 Kephart WC, Wachs TD, Thompson RM, Mobley CB, Fox CD, McDonald JR, Ferguson BS, Young KC, Nie B, Martin JS, Company JM, Pascoe DD, Arnold RD, Moon JR, Roberts MD. Correction to: Ten weeks of branched-chain amino acid supplementation improves select performance and immunological variables in trained cyclists. Amino Acids. PMID 30099596 DOI: 10.1007/s00726-018-2632-5  0.698
2018 Haun CT, Mobley CB, Vann CG, Romero MA, Roberson PA, Mumford PW, Kephart WC, Healy JC, Patel RK, Osburn SC, Beck DT, Arnold RD, Nie B, Lockwood CM, Roberts MD. Author Correction: Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise training. Scientific Reports. 8: 12221. PMID 30097662 DOI: 10.1038/S41598-018-30574-8  0.722
2018 Missaoui WN, Arnold RD, Cummings BS. Toxicological Status of Nanoparticles: What We Know and What We Don't Know. Chemico-Biological Interactions. PMID 30048623 DOI: 10.1016/J.Cbi.2018.07.015  0.754
2018 Haun CT, Mobley CB, Vann CG, Romero MA, Roberson PA, Mumford PW, Kephart WC, Healy JC, Patel RK, Osburn SC, Beck DT, Arnold RD, Nie B, Lockwood CM, Roberts MD. Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise training. Scientific Reports. 8: 11151. PMID 30042516 DOI: 10.1038/S41598-018-29591-4  0.735
2018 Brannen A, Eggert M, Nahrendorf M, Arnold R, Panizzi P. Correlation of 360-degree Surface Mapping In Vivo Bioluminescence with Multi-Spectral Optoacoustic Tomography in Human Xenograft Tumor Models. Scientific Reports. 8: 3321. PMID 29463820 DOI: 10.1038/S41598-018-21668-4  0.769
2018 Pradhan S, Smith AM, Garson CJ, Hassani I, Seeto WJ, Pant K, Arnold RD, Prabhakarpandian B, Lipke EA. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy. Scientific Reports. 8: 3171. PMID 29453454 DOI: 10.1038/S41598-018-21075-9  0.488
2018 Aldawsari MF, Lau VW, Babu RJ, Arnold RD, Platt SR. Pharmacokinetic evaluation of novel midazolam gel formulations following buccal administration to healthy dogs. American Journal of Veterinary Research. 79: 73-82. PMID 29287157 DOI: 10.2460/Ajvr.79.1.73  0.669
2017 Li Y, Rong Y, Bao L, Nie B, Ren G, Zheng C, Amin R, Arnold RD, Jeganathan RB, Huggins KW. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells. Lipids in Health and Disease. 16: 181. PMID 28946872 DOI: 10.1186/S12944-017-0574-7  0.726
2017 Quach ND, Eggert M, Ghosh D, Dawson MR, Arnold R, Cummings BS. Abstract 4465: Glypican-1: A tumor suppressor or an oncogene in human bone metastatic prostate cancer cells Cancer Research. 77: 4465-4465. DOI: 10.1158/1538-7445.Am2017-4465  0.796
2016 Brown JC, Brainard BM, Fletcher DJ, Nie B, Arnold RD, Schmiedt CW. Effect of aminocaproic acid on clot strength and clot lysis of canine blood determined by use of an in vitro model of hyperfibrinolysis. American Journal of Veterinary Research. 77: 1258-1265. PMID 27805439 DOI: 10.2460/Ajvr.77.11.1258  0.78
2016 Epstein KL, Bergren A, Nie B, Arnold RD, Brainard BM. Comparison of the pharmacokinetics of two formulations of hydroxyethyl starch in healthy horses. Journal of Veterinary Pharmacology and Therapeutics. PMID 27650135 DOI: 10.1111/Jvp.12359  0.782
2016 Dixon-Jimenez AC, Brainard BM, Brooks MB, Nie B, Arnold RD, Loper D, Abrams JC, Rapoport GS. Pharmacokinetic and pharmacodynamic evaluation of oral rivaroxaban in healthy adult cats. Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001). PMID 27599304 DOI: 10.1111/Vec.12524  0.77
2016 Scholpa NE, Kolli RT, Moore M, Arnold RD, Glenn TC, Cummings BS. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer. Chemico-Biological Interactions. PMID 27543423 DOI: 10.1016/J.Cbi.2016.08.010  0.655
2016 Kaye S, Johnson S, Arnold RD, Nie B, Davis JT, Gulland F, Abou-Madi N, Fletcher DJ. PHARMACOKINETIC STUDY OF ORAL ε-AMINOCAPROIC ACID IN THE NORTHERN ELEPHANT SEAL (MIROUNGA ANGUSTIROSTRIS). Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians. 47: 438-446. PMID 27468014 DOI: 10.1638/2015-0138.1  0.792
2016 Huang J, Milton A, Arnold RD, Huang H, Smith F, Panizzi JR, Panizzi P. Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems. Journal of Leukocyte Biology. PMID 26884610 DOI: 10.1189/Jlb.3Ru0615-256R  0.618
2016 Pati S, Nie B, Arnold RD, Cummings BS. Extraction, chromatographic and mass spectrometric methods for lipid analysis. Biomedical Chromatography : Bmc. PMID 26762903 DOI: 10.1002/Bmc.3683  0.761
2016 Pradhan S, Smith AM, Garson CJ, Hassani I, Pant K, Arnold RD, Prabhakarpandian B, Lipke EA. Abstract 620: Microfluidic cancer-on-a-chip platform for assessing anti-cancer drug efficacies Cancer Research. 76: 620-620. DOI: 10.1158/1538-7445.Am2016-620  0.482
2016 Smith A, Garson C, Pradhan S, Lipke E, Arnold R, Prabhakarpandian B, Pant K. Abstract 4108:In vitrovascularized model for tumor growth and progression Cancer Research. 76: 4108-4108. DOI: 10.1158/1538-7445.Am2016-4108  0.438
2015 Kephart WC, Wachs TD, Mac Thompson R, Brooks Mobley C, Fox CD, McDonald JR, Ferguson BS, Young KC, Nie B, Martin JS, Company JM, Pascoe DD, Arnold RD, Moon JR, Roberts MD. Ten weeks of branched-chain amino acid supplementation improves select performance and immunological variables in trained cyclists. Amino Acids. PMID 26553453 DOI: 10.1007/S00726-015-2125-8  0.726
2015 Mouli S, Nanayakkara G, AlAlasmari A, Eldoumani H, Fu X, Berlin A, Lohani M, Nie B, Arnold R, Kavazis AN, Smith F, Beyers RJ, Denney T, Dhanasekaran M, Zhong J, et al. The Role of Frataxin in Doxorubicin Mediated Cardiac Hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00182.2015. PMID 26209053 DOI: 10.1152/Ajpheart.00182.2015  0.74
2015 Boozer LB, Platt SR, Haley AC, Linville AV, Kent M, Barron LE, Nie B, Arnold RD. Pharmacokinetic evaluation of immediate- and extended-release formulations of levetiracetam in dogs. American Journal of Veterinary Research. 76: 719-23. PMID 26207970 DOI: 10.2460/Ajvr.76.8.719  0.752
2015 Kang JY, Eggert M, Mouli S, Aljuffali I, Fu X, Nie B, Sheil A, Waddey K, Oldham CD, May SW, Amin R, Arnold RD. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models. Pharmaceutical Research. 32: 852-62. PMID 25158648 DOI: 10.1007/S11095-014-1501-5  0.811
2015 Burton AJ, Giguère S, Arnold RD. Pharmacokinetics, pulmonary disposition and tolerability of liposomal gentamicin and free gentamicin in foals. Equine Veterinary Journal. 47: 467-72. PMID 24943347 DOI: 10.1111/Evj.12309  0.399
2014 Schnellbacher R, Beaufrère H, Vet DM, Arnold RD, Tully TN, Mayer J, Divers SJ. Pharmacokinetics of Levetiracetam in Healthy Hispaniolan Amazon Parrots ( Amazona ventralis ) After Oral Administration of a Single Dose. Journal of Avian Medicine and Surgery. 28: 193-200. PMID 25843318 DOI: 10.1647/2013-057  0.429
2014 Quach ND, Mock JN, Scholpa NE, Eggert MW, Payré C, Lambeau G, Arnold RD, Cummings BS. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells Molecular Pharmaceutics. 11: 3443-3451. PMID 25189995 DOI: 10.1021/Mp500174P  0.808
2014 Quach ND, Arnold RD, Cummings BS. Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease. Biochemical Pharmacology. 90: 338-48. PMID 24907600 DOI: 10.1016/J.Bcp.2014.05.022  0.619
2013 Jung J, Arnold RD, Wicker L. Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier. Colloids and Surfaces. B, Biointerfaces. 104: 116-21. PMID 23298595 DOI: 10.1016/J.Colsurfb.2012.11.042  0.409
2013 Mock JN, Costyn LJ, Wilding SL, Arnold RD, Cummings BS. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer Integrative Biology (United Kingdom). 5: 172-182. PMID 22890797 DOI: 10.1039/C2Ib20108A  0.825
2012 Roy Chaudhuri T, Arnold RD, Yang J, Turowski SG, Qu Y, Spernyak JA, Mazurchuk R, Mager DE, Straubinger RM. Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. Pharmaceutical Research. 29: 3312-24. PMID 22798260 DOI: 10.1007/S11095-012-0823-4  0.761
2012 Zhao Q, Wang L, Cheng R, Mao L, Arnold RD, Howerth EW, Chen ZG, Platt S. Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models. Theranostics. 2: 113-21. PMID 22287991 DOI: 10.7150/Thno.3854  0.422
2012 Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD. Pharmacokinetic assessment of ketanserin in the horse. Journal of Veterinary Pharmacology and Therapeutics. 35: 472-7. PMID 22091605 DOI: 10.1111/J.1365-2885.2011.01346.X  0.741
2012 Schnellbacher RW, Hernandez SM, Tuberville TD, Mayer J, Alhamhoom Y, Arnold RD. The Efficacy of Intranasal Administration of Dexmedetomidine and Ketamine to Yellow-Bellied Sliders (Trachemys scripta scripta) Journal of Herpetological Medicine and Surgery. 22: 91-98. DOI: 10.5818/1529-9651-22.3.91  0.402
2011 Zhu G, Alhamhoom Y, Cummings BS, Arnold RD. Synthesis of lipids for development of multifunctional lipid-based drug-carriers. Bioorganic & Medicinal Chemistry Letters. 21: 6370-5. PMID 21955941 DOI: 10.1016/J.Bmcl.2011.08.103  0.725
2011 Kang JY, Costyn LJ, Nagy T, Cowan EA, Oldham CD, May SW, Arnold RD. The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer. Archives of Biochemistry and Biophysics. 515: 112-9. PMID 21906582 DOI: 10.1016/J.Abb.2011.08.008  0.622
2011 Aljuffali IA, Mock JN, Costyn LJ, Nguyen H, Nagy T, Cummings BS, Arnold RD. Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer. Cancer Biology & Therapy. 12: 407-20. PMID 21709443 DOI: 10.4161/Cbt.12.5.15950  0.799
2011 Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A 2 responsive liposomes Journal of Pharmaceutical Sciences. 100: 3146-3159. PMID 21455978 DOI: 10.1002/Jps.22530  0.774
2010 Aljuffali I, Brainard B, Moore J, Allen D, Robertson T, Arnold R. Pharmacokinetics and Pharmacodynamics of Ketanserin Journal of Equine Veterinary Science. 30: 103-104. DOI: 10.1016/J.Jevs.2010.01.021  0.744
2009 Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Cancer Chemotherapy and Pharmacology. 63: 1049-63. PMID 18791718 DOI: 10.1007/S00280-008-0827-2  0.43
2009 Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ. Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients. Cancer Chemotherapy and Pharmacology. 63: 1035-48. PMID 18791717 DOI: 10.1007/S00280-008-0828-1  0.424
2007 O'Connor R, O'Leary M, Ballot J, Collins CD, Kinsella P, Mager DE, Arnold RD, O'Driscoll L, Larkin A, Kennedy S, Fennelly D, Clynes M, Crown J. A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 59: 79-87. PMID 16642371 DOI: 10.1007/S00280-006-0240-7  0.425
2005 Arnold RD, Mager DE, Slack JE, Straubinger RM. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8856-65. PMID 16361575 DOI: 10.1158/1078-0432.Ccr-05-1365  0.782
2004 Arnold RD, Slack JE, Straubinger RM. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 808: 141-52. PMID 15261807 DOI: 10.1016/J.Jchromb.2004.04.030  0.765
2004 Straubinger RM, Arnold RD, Zhou R, Mazurchuk R, Slack JE. Antivascular and antitumor activities of liposome-associated drugs. Anticancer Research. 24: 397-404. PMID 15152936  0.787
Show low-probability matches.